Type 2 diabetics who were injected once-a-week with with 2 mg of long-acting release Byetta lost an average of 8.4 pounds after 3.75 months (15 weeks) according to a recent study from researchers at Amylin Pharmaceuticals, the makers of the drug. Patients given a dose of 0.8 mg once a week or a placebo did not lose weight. The long-acting release formula is under development by Amylin Pharmaceuticals, Inc. in San Diego, California, USA.
© Copyright 2003-2012 - Larry Hobbs - All Rights Reserved.